Literature DB >> 9745876

The Fanconi syndrome of cystinosis: insights into the pathophysiology.

M Baum1.   

Abstract

Cystinosis is a lysosomal storage disease which is the most-common inherited cause of the Fanconi syndrome. Insights into the pathophysiology of the proximal tubular defect have come from in vitro studies of the cystine-loaded tubule. Proximal tubules loaded with cystine have a generalized proximal tubule transport defect characteristic of the Fanconi syndrome. The decrease in proximal tubular transport with cystine loading is not due to an increase in paracellular permeability with backflux of solute transport from the blood to the tubular lumen, but due to a decrease in active transport. The Na-K-ATPase activity is intact under Vmax conditions in cystine-loaded tubules; however, the production of ATP is severely compromised. The cystine-loaded tubule has a lower intracellular phosphate concentration than that of control tubules. This low intracellular phosphate concentration in cystine-loaded tubules likely plays a critical role in the decrease in intracellular ATP. Preservation of intracellular phosphate at control levels prevents the decrease in intracellular ATP and the proximal tubule respiratory dysfunction with cystine loading. The clinical significance and future directions for investigation are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745876     DOI: 10.1007/s004670050495

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  The reduced expression of proximal tubular transporters in acquired Fanconi syndrome with κ light chain deposition.

Authors:  Akihiro Tojo; Kensuke Asaba; Satoshi Kinugasa; Yoichiro Ikeda; Yukako Shintani; Masashi Fukayama; Masaomi Nangaku
Journal:  Med Mol Morphol       Date:  2015-07-04       Impact factor: 2.309

2.  Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis.

Authors:  Poonam Sansanwal; Li Li; Szu-Chuan Hsieh; Minnie M Sarwal
Journal:  J Inherit Metab Dis       Date:  2010-09-24       Impact factor: 4.982

3.  Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Authors:  Galina Nesterova; Caitlyn Williams; Isa Bernardini; William A Gahl
Journal:  Pediatr Nephrol       Date:  2014-12-20       Impact factor: 3.714

Review 4.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

Review 5.  Lysosomal transport disorders.

Authors:  G M Mancini; A C Havelaar; F W Verheijen
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

6.  A futile cycle, formed between two ATP-dependant gamma-glutamyl cycle enzymes, gamma-glutamyl cysteine synthetase and 5-oxoprolinase: the cause of cellular ATP depletion in nephrotic cystinosis?

Authors:  Akhilesh Kumar; Anand Kumar Bachhawat
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

Review 7.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

8.  Cysteamine prevents inhibition of thiol-containing enzymes caused by cystine or cystine dimethylester loading in rat brain cortex.

Authors:  Virginia Cielo Rech; Luciane Rosa Feksa; Rochele Marisa Müller Fleck; Genaro Azambuja Athaydes; Paula Karina Barcelos Dornelles; Valnes Rodrigues-Junior; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2008-04-17       Impact factor: 3.584

9.  The redox status of cystinotic fibroblasts.

Authors:  Victor Vitvitsky; Marc Witcher; Ruma Banerjee; Jess Thoene
Journal:  Mol Genet Metab       Date:  2009-12-21       Impact factor: 4.797

Review 10.  Cystinosis: the evolution of a treatable disease.

Authors:  Galina Nesterova; William A Gahl
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.